期刊
NANOMEDICINE
卷 15, 期 10, 页码 1001-1018出版社
FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2019-0431
关键词
cancer; extracellular vesicles; glioma; regulatory cells; tumor microenvironment
资金
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302879/2017-0]
- INCT.MCTI/CNPq/CAPES/FAPERGS [465671/2014-4]
- FAPERGS PQG [17/2551-0000 970-3]
- Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05867]
Aim: To characterize a method to isolate glioma-derived extracellular vesicles (GEVs) and understand their role in immune system modulation and glioma progression. Materials & methods: GEVs were isolated by differential centrifugation from C6 cell supernatant and characterized by size and expression of CD9, HSP70, CD39 and CD73. The glioma model was performed by injecting C6 glioma cells into the right striatum of Wistar rats in the following groups: controls (C6 cells alone), coinjection (C6 cells + GEVs) and GEVs by intranasal administration followed by immune cells, tumor size and cells proliferation analyses. Results: GEVs presented uniform size (175 nm), expressed CD9, HSP70, CD39, CD73 and produced adenosine. In vivo, we observed a reduction in tumor size, in cell proliferation (Ki-67) and in a regulatory cell marker (FoxP3). Conclusion: GEVs, administered before or at tumor challenge, have antiproliferative properties and reduce regulatory cells in the glioma microenvironment. Graphical abstract
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据